Cannabidiol – Recent Advances
@article{Mechoulam2007CannabidiolR, title={Cannabidiol – Recent Advances}, author={Raphael Mechoulam and Maximilian Peters and Eric Murillo-Rodr{\'i}guez and Lum{\'i}r Ondřej Hanu{\vs}}, journal={Chemistry \& Biodiversity}, year={2007}, volume={4} }
The aim of this review is to present some of the recent publications on cannabidiol (CBD; 2), a major non‐psychoactive constituent of Cannabis, and to give a general overview. Special emphasis is laid on biochemical and pharmacological advances, and on novel mechanisms recently put forward, to shed light on some of the pharmacological effects that can possibly be rationalized through these mechanisms. The plethora of positive pharmacological effects observed with CBD make this compound a highly…
429 Citations
An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol
- Biology, ChemistryFront. Pharmacol.
- 2017
This review provides an overview of the chemical structure of natural and synthetic CBD derivatives including the molecular targets associated with these compounds.
Potential Effects of Cannabidiol as a Wake-Promoting Agent
- BiologyCurrent neuropharmacology
- 2014
This review will provide experimental evidence regarding the potential role of CBD as a wake-inducing drug and investigate the pharmacological properties of CBD with significant findings.
Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice
- Biology, MedicineBritish journal of pharmacology
- 2008
The effect of cannabidiol on intestinal motility in normal (control) mice and in mice with intestinal inflammation is investigated.
Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy
- Biology, MedicineCannabis and cannabinoid research
- 2016
Current knowledge on the pharmacokinetics and metabolic fate of CBD in humans is summarized, studies on the biological activity of CBD metabolites either in vitro or in vivo are reviewed, and relevant drug–drug interactions are discussed.
Emerging Roles of Cannabinoids and Synthetic Cannabinoids in Clinical Experimental Models.
- Biology, MedicineAdvances in experimental medicine and biology
- 2021
This chapter provides an overview of the endocannabinoid system under certain physiopathological conditions, with a focus on neurological, oncologic, and metabolic disorders.
the role of cannabinoids in the treatment of children with cancer
- Biology
- 2017
Cannabinoids are a heterogeneous group of compounds that exhibit activity by binding to specific receptors called cannabinoid receptors, and the synthetic analogs of both groups are called synthetic cannabinoids.
Cannabinoids-Promising Antimicrobial Drugs or Intoxicants with Benefits?
- Biology, MedicineAntibiotics
- 2020
It is time to discuss whether cannabinoids are promising antimicrobial drug candidates or overhyped intoxicants with benefits.
Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action.
- Biology, MedicineRevista brasileira de psiquiatria
- 2008
In the last 45 years it has been possible to demonstrate that CBD has a wide range of pharmacological effects, many of which being of great therapeutic interest, but still waiting to be confirmed by clinical trials.
Medicinal Chemistry Endeavors around the Phytocannabinoids
- Chemistry, BiologyChemistry & biodiversity
- 2007
This review summarizes past as well as recent developments in the structure–activity relationships of phytocannabinoids.
References
SHOWING 1-10 OF 71 REFERENCES
Cannabidiol: An Overview of Some Pharmacological Aspects
- MedicineJournal of clinical pharmacology
- 2002
The authors present a review on the chemistry of CBD and discuss the anticonvulsive, antianxiety, antipsychotic, antinausea, and antirheumatoid arthritic properties of CBD.
Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects.
- BiologyChemistry and physics of lipids
- 2002
Synthesis of a primary metabolite of cannabidiol.
- BiologyOrganic letters
- 2000
This work reports the first total synthesis of 7-hydroxycannabidiol 2, a primary metabolite of cannABidiol, in an eight-step procedure, which produces numerous, potentially therapeutic pharmacological effects.
The Pharmacological Actions of Cannabidiol
- Biology
- 2005
The current understanding of the mechanism of action of cannabidiol is discussed, focusing on some of the central and peripheral pharmacological effects of this exciting potential therapeutic agent.
New cannabidiol derivatives: synthesis, binding to cannabinoid receptor, and evaluation of their antiinflammatory activity.
- Chemistry, BiologyJournal of medicinal chemistry
- 2006
Surprisingly, it is found that hydrogenated CBD and CBD-DMH exhibit good binding to the cannabinoid receptor (CB(1), and demonstrate bioactivities different from their original compounds.
Synthesis of cannabidiols via alkenylation of cyclohexenyl monoacetate.
- Chemistry, BiologyOrganic letters
- 2006
The key reaction is nickel-catalyzed allylation of 2-cyclohexene-1,4-diol monoacetate with a new reagent, (alkenyl)ZnCl/TMEDA, which gives a S(N)2-type product with 94% regioselectivity in good yield.
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
- Biology, ChemistryBritish journal of pharmacology
- 2001
Results suggest that VR1 receptors, or increased levels of endogenous AEA, might mediate some of the pharmacological effects of CBD and its analogues, and (−)‐5′‐DMH‐CBD represents a valuable candidate for further investigation as inhibitor of AEA uptake and a possible new therapeutic agent.
A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol.
- Medicine, BiologyMedical hypotheses
- 2006
The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells.
- Biology, MedicineBiochemical pharmacology
- 2006
Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell Lines
- Biology, ChemistryJournal of Pharmacology and Experimental Therapeutics
- 2004
Evaluating the in vitro antiproliferative ability of cannabidiol (CBD), a nonpsychoactive cannabinoid compound, on U87 and U373 human glioma cell lines suggests a possible application of CBD as an antineoplastic agent.